Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial
Lucia Del Mastro(Ospedale Policlinico San Martino), Paolo Bruzzi(Alleanza Contro il Cancro), Stefano Tamberi(Azienda Unità Sanitaria Locale Della Romagna), Francesca Poggio(Ospedale Policlinico San Martino), Ornella Garrone(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo), Fabio Puglisi(University of Udine), C. Barone(CTO Hospital), Claudia Bighin(Azienda Ospedaliera S.Maria), Stefania Gori(Ospedale Sacro Cuore Don Calabria), Filippo Montemurro(Roche (Switzerland)), Grazia Arpino(University of Naples Federico II), Gabriella Moretti(Istituti di Ricovero e Cura a Carattere Scientifico), Mauro Mansutti(Ospedale Santa Maria della Misericordia di Udine), Alessandra Fabi(Agostino Gemelli University Polyclinic), Giancarlo Bisagni, Antonio Frassoldati(Italian Oncology Group of Clinical Research), Riccardo Ponzone(Candiolo Cancer Institute), Giovanni Sanna(University of Sassari), Enrico Campadelli(Ospedale per gli Infermi), Sabino De Placido, Matteo Lambertini(Ospedale Policlinico San Martino), Ylenia Urracci, Alberto Ballestrero(Ospedale Policlinico San Martino), F. Cognetti(Sapienza University of Rome), Silvia Mura(Ospedale SS. Annunziata), Antonio Durando(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Andrea Michelotti(University of Pisa), Laura Amaducci(Ospedale degli Infermi)
Cited by 86
Related Papers
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
|The Lancet|2007|912
Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
|Journal of Clinical Oncology|2010|887
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830
Cancer and fertility preservation: international recommendations from an expert meeting
|BMC Medicine|2016|779
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751